** Citi analysts lower price target for nib Holdings NHF.AX to A$6.9; retain "neutral" rating
** The medical insurer, nib, on Tuesday said it now expects an operating loss for its New Zealand business instead of the previously expected profit
** Citi sees an A$2 million ($1.30 million) underlying operating loss for co's New Zealand unit
** Brokerage expects co to make A$236 million in FY25 underlying operating profit, near the lower end of nib's retained guidance range
** Also reduces FY25 and FY26 earnings per share estimate by 4% and 2%, respectively
** 5 out of 11 analysts rate the stock "hold", 5 rate it "buy" or higher, 1 rates its "sell"; median PT is A$7.03 - data compiled by LSEG
** Stock last up 25.2% YTD
($1 = 1.5418 Australian dollars)
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((JasmeenAraIslam.Shaikh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.